BlackRock’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
3,846,454
+79,742
| +2% | +$360K | ﹤0.01% | 3068 |
|
|
2025
Q1 | $17.5M | Sell |
3,766,712
-73,452
| -2% | -$341K | ﹤0.01% | 2982 |
|
|
2024
Q4 | $26.7M | Buy |
3,840,164
+938,673
| +32% | +$6.51M | ﹤0.01% | 2821 |
|
|
2024
Q3 | $15.4M | Buy |
2,901,491
+541,398
| +23% | +$2.87M | ﹤0.01% | 3150 |
|
|
2024
Q2 | $8.83M | Buy |
2,360,093
+53,084
| +2% | +$199K | ﹤0.01% | 3393 |
|
|
2024
Q1 | $16.3M | Sell |
2,307,009
-64,971
| -3% | -$458K | ﹤0.01% | 3052 |
|
|
2023
Q4 | $13.4M | Sell |
2,371,980
-1,322,688
| -36% | -$7.47M | ﹤0.01% | 3179 |
|
|
2023
Q3 | $17.7M | Sell |
3,694,668
-165,688
| -4% | -$794K | ﹤0.01% | 2957 |
|
|
2023
Q2 | $26.4M | Buy |
3,860,356
+250,935
| +7% | +$1.72M | ﹤0.01% | 2805 |
|
|
2023
Q1 | $28.1M | Buy |
3,609,421
+10,885
| +0.3% | +$84.8K | ﹤0.01% | 2743 |
|
|
2022
Q4 | $27.4M | Buy |
3,598,536
+128,304
| +4% | +$976K | ﹤0.01% | 2813 |
|
|
2022
Q3 | $28.4M | Buy |
3,470,232
+157,663
| +5% | +$1.29M | ﹤0.01% | 2806 |
|
|
2022
Q2 | $32M | Buy |
3,312,569
+184,177
| +6% | +$1.78M | ﹤0.01% | 2755 |
|
|
2022
Q1 | $43.9M | Buy |
3,128,392
+774,628
| +33% | +$10.9M | ﹤0.01% | 2621 |
|
|
2021
Q4 | $48.1M | Buy |
2,353,764
+285,087
| +14% | +$5.82M | ﹤0.01% | 2651 |
|
|
2021
Q3 | $46.1M | Buy |
2,068,677
+518,792
| +33% | +$11.6M | ﹤0.01% | 2680 |
|
|
2021
Q2 | $35.2M | Buy |
+1,549,885
| New | +$35.2M | ﹤0.01% | 2889 |
|